Shares of Savaria Co. (TSE:SIS – Get Free Report) have received an average rating of “Buy” from the nine analysts that are covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$33.33.
SIS has been the subject of several recent research reports. TD Securities upgraded shares of Savaria to a “strong-buy” rating in a research report on Friday, July 24th. TD lifted their price objective on shares of Savaria from C$31.00 to C$35.00 and gave the company a “buy” rating in a research report on Wednesday, April 15th. Desjardins boosted their target price on shares of Savaria from C$32.00 to C$35.00 and gave the company a “buy” rating in a research note on Thursday, April 16th. ATB Cormark Capital Markets upped their target price on shares of Savaria from C$32.00 to C$35.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Finally, Stifel Nicolaus raised their price target on shares of Savaria from C$29.00 to C$31.00 and gave the company a “buy” rating in a research note on Wednesday, April 8th.
View Our Latest Stock Analysis on SIS
Savaria Stock Performance
Savaria (TSE:SIS – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. The firm had revenue of C$235.55 million for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%. Equities research analysts predict that Savaria will post 1.2048518 EPS for the current year.
Insiders Place Their Bets
In related news, Director Peter Allen Drutz sold 15,264 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of C$27.48, for a total value of C$419,454.72. Following the completion of the transaction, the director directly owned 104,987 shares of the company’s stock, valued at C$2,885,042.76. This represents a 12.69% decrease in their position. Also, Director Marcel Bourassa sold 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The shares were sold at an average price of C$29.53, for a total value of C$221,475.00. Following the completion of the sale, the director owned 225,431 shares in the company, valued at approximately C$6,656,977.43. This represents a 3.22% decrease in their ownership of the stock. In the last ninety days, insiders have sold 62,500 shares of company stock valued at $1,761,124. Corporate insiders own 17.45% of the company’s stock.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
